Taking up PILs by Punjab LoP Partap Singh Bajwa and SAD leader Daljit Singh Cheema, court gave state election commission time ...

Beijing’s latest show of force came in the form of its Liaoning carrier strike group launching aircraft near Okinawa ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract from the BRAVO study at the Society of Urologic Oncology 2025 Annual Meeting (SUO) ...

An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly ...

Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, and MEDSIR (Medica Scientia Innovation ...

Enhertu (trastuzumab Deruxtecan [T-DXd]) treated patients continue to be eligible for enrollment in FLAMINGO-01. The Company believes that GLSI-100 will synergize with any trastuzumab based treatment ...

Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology  Oslo, Norway, 8 December 2025 - Oncoinvent, a clinical stage, radiopharmaceutical ...

Antigen spreading was evaluated in a subset of Phase 2 patients to assess the ability of ELI-002 7P to broaden immune ...

Xu, W. , Xing, X. and Cheng, S. (2025) Urine-Based Liquid Biopsy for Detecting Recurrence of Bladder Cancer. International ...

Approximately 8,000 people in Europe are living with C3G or primary IC-MPGN If approved, Aspaveli (pegcetacoplan) would be the first C3G and primary ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General ...